SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Apricus Biosciences
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Mirror Image9/1/2015 12:16:17 PM
   of 2026
 
Thoughts from today's press release.

* Finally the country that had Vitaros partnered first has launched. Only took 5 years ( almost ) after it was partnered.

* We should see royalties of around $300 K + on the next 10 Q ( for sales from 2Q 2015). They noted a 103% increase in sales compared to the previous quarter. That should put the units sold at 150,000 + ( multiplied by $2.25 ).

* We have had National approvals derived from the latest 12 EMA countries where Vitaros was recently approved.

In total, Vitaros is currently approved under the European Decentralized Procedure ("DCP") in twenty-two countries, of which fourteen have further approved Vitaros for commercialization at the national phase level of the DCP approval process.

Read more: http://www.nasdaq.com/press-release/apricus-biosciences-announces-the-launch-of-its-novel-topical-treatment-for-erectile-dysfunction-i-20150901-00230#ixzz3kVJAhvEP

The original amount of National approvals was 10. That means that 4 more countries have given their national approval. Again, Sandoz had previously ordered Vitaros Units for Denmark and Norway. These two countries could be getting ready to launch.

Going back to the royalty revenues. Based on the last quarter and projecting it out a year, that would generate Apricus $ 1.2 M in royalties. Spain launched towards the middle of the quarter and France's launch was only in the last month of that quarter.

It might be safe to project that this 3Q 2015 would have the partners selling units in the 200,000 - 250,000 area ( especially given that Italy will have contributed with 1 month of Vitaros Sales ). I think this number of units sold is attainable even if Germany doesn't contribute towards this total.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News